| 1 |
31041717 | First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience. | 2020 Jan |
1 |
| 2 |
29757876 | A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer. | 2018 Jul |
5 |
| 3 |
28345825 | Comparison of Hypersensitivity Reactions to Carboplatin Retreatment in Gynecologic Cancer Patients between One and Two Hour Infusions: a Randomized Trial Study | 2017 Feb 1 |
3 |
| 4 |
25030546 | 4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study. | 2015 Jun |
2 |
| 5 |
26298407 | Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy. | 2015 Nov |
2 |
| 6 |
23867999 | Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions. | 2013 Aug 20 |
7 |
| 7 |
24372428 | [Hypersensitivity reactions to carboplatin and paclitaxel - our five-years experiences]. | 2013 Dec |
3 |
| 8 |
19501233 | Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management. | 2009 Jun |
4 |
| 9 |
18098210 | Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience. | 2008 Feb 15 |
2 |